Pentazocine abuse and problems of withdrawal.
D014150:Antipsychotic Agents / Q000009:adverse effects; D003221:Confusion / Q000139:chemically induced; D003693:Delirium / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008691:Methadone / Q000627:therapeutic use; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010423:Pentazocine; D010640:Phenothiazines; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders; D013997:Time Factors
D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D010423:Pentazocine; D008691:Methadone